Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blinded Within Dose, Controlled, Safety and Immunogenicity Study of GAS Vaccine Candidate in Healthy Individuals.

NCT04882514 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT04882514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04882514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blinded Within Dose, Controlled, Safety and Immunogenicity Study of GAS Vaccine Candidate in Healthy Individuals.
Lead sponsor
University of Alberta
Phase
Phase 1/2
Overall status
Completed
Start date
November 7, 2022
Completion date
May 12, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

group a streptococcal infection